Optic Neuritis: An Update Typical and Atypical Optic Neuritis

REFERENCES

• Hickman SJ, Dalton CM, Miller DH, et al. Management of acute optic neuritis. Lancet 2002; 360: 1953–1962
   PubMed Web of Science ®Google Scholar
• The Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: Final Optic Neuritis Treatment Trial follow-up. Arch Neurol. 2008; 65: 727–732
   PubMed Web of Science ®Google Scholar
• Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808–817
   PubMed Web of Science ®Google Scholar
• Pirko I, Blauwet LK, Lesnick TG, et al. The natural history of recurrent optic neuritis. Arch Neurol. 2004; 61: 1401–1405
   PubMedGoogle Scholar
• Kidd D, Burton B, Plant GT, et al. Chronic relapsing inflammatory optic neuropathy (CRION): A newly recognised steroid responsive syndrome seemingly distinct from sarcoidosis. Brain 2003; 126: 276–284
   PubMed Web of Science ®Google Scholar
• Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005; 4: 111–121
   PubMed Web of Science ®Google Scholar
• Balcer LJ. Optic neuritis. N Engl J Med. 2006; 354: 1273–1280
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: A population-based study in Olmsted County, Minnesota. Neurology 1995; 45: 244–250
   PubMed Web of Science ®Google Scholar
• Jin YP, Pedro-Cuesta J, Soderstrom M, et al. Incidence of optic neuritis in Stockholm, Sweden 1990–1995: I. Age, sex, birth and ethnic-group related patterns. J Neurol Sci. 1998; 159: 107–114
   PubMed Web of Science ®Google Scholar
• MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123: 665–676
   PubMed Web of Science ®Google Scholar
• Davis FA, Bergen D, Schauf C, et al. Movement phosphenes in optic neuritis: A new clinical sign. Neurology 1976; 26: 1100–1104
   PubMedGoogle Scholar
• Keltner JL, Johnson CA, Spurr JO, et al. Baseline visual field profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1993; 111: 231–234
   PubMedGoogle Scholar
• Optic Neuritis Study Group. The clinical profile of optic neuritis: Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991; 109: 1673–1678
   PubMed Web of Science ®Google Scholar
• Phillips PH, Newman NJ, Lynn MJ. Optic neuritis in African Americans. Arch Neurol. 1998; 55: 186–192
   PubMedGoogle Scholar
• Perkin GD, Rose FC. Optic Neuritis and Its Differential Diagnosis. Oxford University Press, Oxford 1979
   Google Scholar
• Hickman SJ, Toosy AT, Miszkiel KA, et al. Visual recovery following acute optic neuritis: A clinical, electrophysiological and magnetic resonance imaging study. J Neurol. 2004; 251: 996–1005
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Optic Neuritis Study Group. Optic Neuritis Treatment Trial: One-year follow-up results. Arch Ophthalmol. 1993; 111: 773–775
   PubMed Web of Science ®Google Scholar
• Brusa A, Jones SJ, Plant GT. Long–term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain 2001; 124: 468–479
   PubMed Web of Science ®Google Scholar
• Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol. 1999; 43: 127–132
   PubMed Web of Science ®Google Scholar
• Wakakura M, Mashimo K, Oono S, et al. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Jpn J Ophthalmol. 1999; 43: 133–138
   PubMedGoogle Scholar
• Bee Y-S, Lin M-C, Wang C-C, et al. Optic neuritis: Clinical analysis of 27 cases. Kaohsiung J Med Sci. 2003; 19: 105–112
   PubMedGoogle Scholar
• Wang J-C, Tow S, Aung T, et al. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol. 2001; 29: 312–315
   PubMed Web of Science ®Google Scholar
• Chuenkongkaew W, Chirapapaisan N. Optic neuritis: Characteristics and visual outcome. J Med Assoc Thai. 2003; 86: 238–243
   PubMedGoogle Scholar
• Singh Sethi H, Menon V, Sharma P, et al. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: A clinical case series. Indian J Ophthalmol. 2006; 54: 177–183
   PubMedGoogle Scholar
• Pokroy R, Modi G, Saffer D. Optic neuritis in an urban black African community. Eye 2001; 15: 469–473
   PubMedGoogle Scholar
• Alvarez G, Cardenas M. Multiple sclerosis following optic neuritis in Chile. J Neurol Neurosurg Psychiatry 1989; 52: 115–117
   PubMedGoogle Scholar
• Beck RW. Optic Neuritis. Walsh and Hoyt's Clinical Neuro-Ophthalmology 5th, NR Miller, NJ Newman. Williams and Wilkins, Baltimore 1998; 599–647
   Google Scholar
• Slamovits TL, Rosen CE, Cheng KP, et al. Visual recovery in patients with optic neuritis and visual loss to no light perception. Am J Ophthalmol. 1991; 111: 209–214
   PubMedGoogle Scholar
• Kupersmith MJ, Gal RL, Beck RW, et al. Visual function at baseline and 1 month in acute optic neuritis: Predictors of visual outcome. Neurology 2007; 69: 508–514
   PubMedGoogle Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359: 1221–1231
   PubMed Web of Science ®Google Scholar
• Hickman SJ. Optic nerve imaging in multiple sclerosis. J Neuroimaging 2007; 17(Suppl.1)42S–45S
   Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axon loss and visual dysfunction in optic neuritis. Ann Neurol. 2005; 58: 383–391
   PubMed Web of Science ®Google Scholar
• Toosy AT, Hickman SJ, Miszkiel KA, et al. Adaptive cortical plasticity in higher visual processing areas after acute optic neuritis. Ann Neurol. 2005; 57: 622–633
   PubMedGoogle Scholar
• Frohman EM, Costello F, Stuve O, et al. Modeling axonal degeneration within the anterior visual system: Implications for demonstrating neuroprotection in MS. Arch Neurol. 2008; 65: 26–35
   PubMedGoogle Scholar
• The Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: Experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol. 2004; 137: 77–83
   PubMedGoogle Scholar
• Optic Neuritis Study Group. Visual function 15 years after optic neuritis: A final follow-up report from the optic neuritis treatment trial. Ophthalmology 2008; 115: 1079–1082
   PubMed Web of Science ®Google Scholar
• de la Cruz J, Kupersmith MJ. Clinical profile of simultaneous bilateral optic neuritis in adults. Br J Ophthalmol. 2006; 90: 551–554
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Anderson MM, Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992; 326: 581–588
   PubMed Web of Science ®Google Scholar
• Newman NJ, Lessell S, Winterkorn JM. Optic chiasmal neuritis. Neurology 1991; 41: 1203–1210
   PubMed Web of Science ®Google Scholar
• da Silva Costa RM, Santos AC, Costa LS. An unusual chiasmal visual defect in a patient with neuromyelitis optica: Case report. Arq Bras Oftalmol. 2007; 70: 153–155
   PubMedGoogle Scholar
• Vedula SS, Brodney-Folse S, Gal RL, et al. Corticosteroids for treating optic neuritis. Cochrane Database of Systematic Reviews. 2007, Issue 1. Art. No.: CD001430
   Google Scholar
• Sellebjerg F, Nielsen HS, Frederiksen JL, et al. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology 1999; 52: 1479–1484
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993; 329: 1764–1769
   PubMed Web of Science ®Google Scholar
• Kupersmith MJ, Burde RM, Warren FA, et al. Autoimmune optic neuropathy: Evaluation and treatment. J Neurol Neurosurg Psychiatry 1988; 51: 1381–1386
   PubMed Web of Science ®Google Scholar
• Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: Clinical and radiographic features. Arch Ophthalmol. 2001; 119: 1299–1306
   PubMedGoogle Scholar
• Papais-Alvarenga RM, Carellos SC, Alvarenga MP, et al. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol. 2008; 126: 12–16
   PubMedGoogle Scholar
• Galindo-Rodríguez G, Aviña-Zubieta JA, Pizarro S, et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: An open trial. Am J Med. 1999; 106: 65–69
   PubMedGoogle Scholar
• Koczman JJ, Rouleau J, Gaunt M, et al. Neuro-ophthalmic sarcoidosis: The University of Iowa experience. Semin Ophthalmol. 2008; 23: 157–168
   PubMedGoogle Scholar
• Kansu T, Kirkali P, Kansu E, et al. Optic neuropathy in Behcet's disease. J Clin Neuro-Ophthalmol. 1989; 9: 277–280
   PubMedGoogle Scholar
• Merle H, Smadja D, Merle S, et al. Visual phenotype of multiple sclerosis in the Afro-Caribbean population and the influence of migration to metropolitan France. Eur J Ophthalmol. 2005; 15: 392–399
   PubMedGoogle Scholar
• Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007; 6: 805–815
   PubMed Web of Science ®Google Scholar
• Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003; 2: 117–127
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112
   PubMed Web of Science ®Google Scholar
• Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin 4 water channel. J Exp Med. 2005; 202: 473–477
   PubMed Web of Science ®Google Scholar
• Marignier R, de Sèze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: A French experience. Mult Scler. 2008; 14: 440–445
   PubMedGoogle Scholar
• Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007; 4: e133
   PubMedGoogle Scholar
• de Seze J, Arndt C, Jeanjean L, et al. Relapsing inflammatory optic neuritis: Is it neuromyelitis optica?. Neurology 2008; 70: 2075–2076
   PubMed Web of Science ®Google Scholar
• Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70: 2197–2200
   PubMed Web of Science ®Google Scholar
• Kikuchi S, Fukazawa T. OSMS is NMO, but not MS: Confirmed by NMO-IgG?. Lancet Neurol. 2005; 4: 594–595
   PubMedGoogle Scholar
• Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206–1223
   PubMed Web of Science ®Google Scholar
• Tanaka M, Tanaka K, Komori M, et al. Anti-aquaporin 4 antibody in Japanese multiple sclerosis: The presence of optic-spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody. J Neurol Neurosurg Psychiatry. 2007; 78: 990–992
   PubMed Web of Science ®Google Scholar
• Hickman SJ. Inflammatory optic neuropathies. Current Ocular Therapy 6th, FH Roy, FW Fraunfelder, FT Fraunfelder. Saunders Elsevier. 2008; 578–581
   Google Scholar
• Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology 1994; 101: 1771–1778
   PubMed Web of Science ®Google Scholar
• Ruprecht K, Klinker E, Dintelmann T, et al. Plasma exchange for severe optic neuritis: Treatment of 10 patients. Neurology 2004; 63: 1081–1083
   PubMed Web of Science ®Google Scholar
• Weinshenker BG, O’Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999; 46: 878–886
   PubMed Web of Science ®Google Scholar
• Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007; 13: 128–132
   PubMed Web of Science ®Google Scholar
• Roed HG, Langkilde A, Sellebjerg F, et al. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 2005; 64: 804–810
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, O’Brien PC, Petterson TM, et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 2001; 56: 1514–1522
   PubMed Web of Science ®Google Scholar
• Bakker J, Metz L. Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci. 2004; 31: 265–7
   PubMedGoogle Scholar
• Watanabe S, Misu T, Miyazawa I. Low-dose corticosteroids reduce relapses in neuromyelitis optica: A retrospective analysis. Mult Scler. 2007; 13: 968–974
   PubMed Web of Science ®Google Scholar
• Giovannoni G. To test or not to test: NMO-IgG and optic neuritis. Neurology 2008; 70: 2192–2193
   PubMedGoogle Scholar
• Cree BAC, Lamb S, Morgan K. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005; 64: 1270–1272
   PubMed Web of Science ®Google Scholar